Biomarkers in chronic fatigue syndrome: evaluation of natural killer cell function and dipeptidyl peptidase IV/CD26.

Biomarkers in chronic fatigue syndrome: evaluation of natural killer cell function and dipeptidyl peptidase IV/CD26.

Chronic Fatigue Syndrome (CFS) studies from our laboratory and others described decreased natural killer cell cytotoxicity (NKCC) and elevated proportion of lymphocytes expressing the activation marker, dipeptidyl peptidase IV (DPPIV) also known as CD26. However, neither these assays nor other labor...

Full description

Bibliographic Details
Main Authors: Mary A Fletcher, Xiao R Zeng, Kevin Maher, Silvina Levis, Barry Hurwitz, Michael Antoni, Gordon Broderick, Nancy G Klimas
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2010-05-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC2876037?pdf=render

Internet

http://europepmc.org/articles/PMC2876037?pdf=render

Similar Items